SCHEMBL29133757

SCHEMBL29133757

CCC1(Nc2c(C#N)cnc3ccc(-c4cnc5[nH]ncc5c4)cc23)C=CC=CC1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 6/20 0.55
▸ PRKDC P78527 4/20 0.55
▸ PIK3CA P42336 4/20 0.41
▸ AKT1 P31749 1/20 0.41
▸ ABL1 P00519 2/20 0.36
▸ TNIK Q9UKE5 2/20 0.35
▸ SRC P12931 2/20 0.34
▸ FLT1 P17948 1/20 0.34
▸ KDR P35968 1/20 0.34
▸ SYK P43405 1/20 0.34
▸ PIK3C3 Q8NEB9 3/20 0.33
▸ MELK Q14680 3/20 0.33
▸ DYRK1A Q13627 1/20 0.33
▸ DYRK1B Q9Y463 1/20 0.33
▸ PIK3CD O00329 1/20 0.33
▸ MTOR P42345 1/20 0.33
▸ PRMT5 O14744 1/20 0.32
▸ WDR77 Q9BQA1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29133740 1.00 EGFR (0.55) EGFRPRKDCPIK3CAAKT1ABL1
SCHEMBL29133778 0.89 PIK3CA (0.44) EGFRPRKDCPIK3CAPIK3CDMTOR
SCHEMBL29133705 0.88 EGFR (0.41) EGFRPRKDCPIK3CAABL1SRC
SCHEMBL29133713 0.88 EGFR (0.44) EGFRPRKDCPIK3CAABL1SRC
SCHEMBL29133699 0.87 EGFR (0.40) EGFRPRKDCPIK3CAABL1SRC
SCHEMBL29133758 0.85 EGFR (0.42) EGFRPRKDCPIK3CAABL1TNIK
SCHEMBL29133729 0.85 EGFR (0.52) EGFRPRKDCPIK3CAABL1SRC
SCHEMBL29133769 0.84 PIK3CA (0.46) PIK3CAPIK3CDMTOR
SCHEMBL29133737 0.84 MAP4K4 (0.42) EGFRPRKDCPIK3CAABL1SRC
SCHEMBL29133763 0.83 MELK (0.38) EGFRPRKDCPIK3CAABL1SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117295716-A Substituted aminobenzyl heteroaryl compounds as EGFR and/or PI3K inhibitors 麦克尼斯迪克治疗有限公司 2023-12-26 — — CN disclosed
Send feedback